After More Than Three Months, the Company Has Refused to Engage on Steel’s Proposal
Steel Believes Directors Breached Their Fiduciary Duties by Demanding Dismissal of Claims Against Them in Exchange for Diligence
YOKNEAM, Israel, Oct. 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the third
IRVINE, Calif., Sept. 9, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, announces the launch of Morpheus8 Cool, the next evolution of its renowned Morpheus8
NEW YORK, Sept. 1, 2026 /PRNewswire/ -- Equity Insider News Commentary - The global medical aesthetics market has quietly become one of the most durable growth stories in healthcare. Multiple market-research firms size
YOKNEAM, Israel, Aug. 5, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- American News Group News Commentary - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator
Believes Dr. Ron's Financial Ties and More Than Two Decades of Intertwined Business Interests with CEO Moshe Mizrahy Render Her Unable to Exert Independent Oversight
Special Committee Did Not Accomplish Anything
Questions Whether Management is Steering Reported Results to Fit the CEO’s Lowball Bid
Demands the Group Led by CEO Moshe Mizrahy Cure Its Disclosure Deficiencies
Calls on the Board to Reschedule the Annual General
YOKNEAM, Israel, July 13, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the second
YOKNEAM, Israel, July 10, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD) (the "Company") confirmed that its Board of Directors (the "Board") has received the unsolicited letter and acquisition proposal
Superior Proposal Exceeds Conflicted CEO-Led $16.20 Insider Bid and Provides Optional Shareholder Rollover
Demands the Board Take Immediate Action to Remove Incapable and Conflicted CEO
Calls on Board to Form a
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of InMode Ltd. ("InMode" or the "Company")
Law Offices of Howard G. Smith announces an investigation on behalf of InMode Ltd. ("InMode" or the "Company") (NASDAQ: INMD) investors concerning the Company’s possible violations of federal securities
The Law Offices of Frank R. Cruz announces an investigation of InMode Ltd. ("InMode" or the "Company") (NASDAQ: INMD) on behalf of investors concerning the Company’s possible violations of federal
DOMA ASSERTS THAT THE $16.20 PER SHARE OFFER MATERIALLY UNDERVALUES INMODE AND ITS LONG-TERM POTENTIALDOMA BELIEVES THE BID EXPLOITS THE DEPRESSED VALUATIONS CREATED BY YEARS OF CEO-LED UNDERPERFORMANCEDOMA EXPLICITLY
